USD 0.0
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2009 | -110.53 Thousand USD | -133.94% |
2008 | -136.86 Thousand USD | 90.23% |
2007 | -888.93 Thousand USD | -155.19% |
2006 | -393.45 Thousand USD | -600.94% |
2005 | -49.69 Thousand USD | 34.33% |
2004 | -75.67 Thousand USD | 10.26% |
2003 | -84.33 Thousand USD | -212.67% |
2002 | -26.97 Thousand USD | -91.96% |
2001 | -14.05 Thousand USD | -46.44% |
2000 | -9595.00 USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2010 Q1 | -21.91 Thousand USD | 82.71% |
2010 Q3 | 26.01 Thousand USD | 118.55% |
2010 Q2 | -140.19 Thousand USD | -539.79% |
2009 Q3 | -47.72 Thousand USD | 56.15% |
2009 Q1 | 79.68 Thousand USD | 23.68% |
2009 Q4 | -126.72 Thousand USD | -165.57% |
2009 Q2 | -108.81 Thousand USD | -236.56% |
2009 FY | - USD | -133.94% |
2008 Q3 | -80.66 Thousand USD | 45.63% |
2008 Q4 | 64.42 Thousand USD | 179.87% |
2008 FY | - USD | 90.23% |
2008 Q1 | 27.73 Thousand USD | 48.61% |
2008 Q2 | -148.35 Thousand USD | -634.88% |
2007 Q3 | -186.13 Thousand USD | 52.73% |
2007 Q2 | -393.77 Thousand USD | -20.18% |
2007 Q1 | -327.66 Thousand USD | -28817.53% |
2007 FY | - USD | -155.19% |
2007 Q4 | 18.66 Thousand USD | 110.03% |
2006 Q1 | 4666.00 USD | 165.01% |
2006 Q2 | -175.14 Thousand USD | -3853.66% |
2006 Q3 | 59.4 Thousand USD | 133.92% |
2006 FY | - USD | -600.94% |
2006 Q4 | 1141.00 USD | -98.08% |
2005 FY | - USD | 34.33% |
2005 Q1 | -22.31 Thousand USD | -27.77% |
2005 Q3 | -8213.00 USD | -383.12% |
2005 Q2 | -1700.00 USD | 92.38% |
2005 Q4 | -7177.00 USD | 12.61% |
2004 Q4 | -17.46 Thousand USD | 40.23% |
2004 Q1 | -18.22 Thousand USD | -6.3% |
2004 Q2 | -11.09 Thousand USD | 39.13% |
2004 FY | - USD | 10.26% |
2004 Q3 | -29.22 Thousand USD | -163.51% |
2003 FY | - USD | -212.67% |
2003 Q4 | -17.14 Thousand USD | 1.35% |
2003 Q3 | -17.37 Thousand USD | 3.44% |
2003 Q2 | -17.99 Thousand USD | -1124.19% |
2003 Q1 | -23 Thousand USD | 106.77% |
2002 Q2 | -6681.00 USD | -480.25% |
2002 Q4 | -25.95 Thousand USD | -160.26% |
2002 FY | - USD | -91.96% |
2002 Q1 | -23 Thousand USD | 114.55% |
2002 Q3 | -9974.00 USD | -49.29% |
2001 Q4 | -12.07 Thousand USD | -106.92% |
2001 Q3 | -5835.00 USD | -113.03% |
2001 Q2 | -2739.00 USD | 31.32% |
2001 Q1 | -3988.00 USD | -168.37% |
2001 FY | - USD | -46.44% |
2000 Q3 | -7993.00 USD | -1182.99% |
2000 Q4 | -1486.00 USD | 81.41% |
2000 Q1 | -468.00 USD | 8.06% |
2000 FY | - USD | 0.0% |
2000 Q2 | -623.00 USD | -33.12% |
1999 Q4 | -509.00 USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
American Medical Technologies Inc. | -963.95 Thousand USD | 88.534% |
Ansell Limited | 209.86 Million USD | 100.053% |
Ansell Limited | 206.3 Million USD | 100.054% |
BG Medicine, Inc. | - USD | Infinity% |
Biotage AB (publ) | 42.83 Million USD | 100.258% |
BioLife Sciences Inc. | - USD | Infinity% |
CB Scientific, Inc. | -1.62 Million USD | 93.198% |
Psykey, Inc. | -1.29 Million USD | 91.467% |
ConvaTec Group Plc | 455.5 Million USD | 100.024% |
ConvaTec Group Plc | 455.5 Million USD | 100.024% |
Encision Inc. | -544.19 Thousand USD | 79.689% |
Golden Valley Development, Inc | -141.81 Thousand USD | 22.057% |
Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -0.547% |
Innovative MedTech Inc. | -7.67 Million USD | 98.56% |
LifePoint, Inc. | -14.2 Million USD | 99.222% |
Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 98.213% |
Paradigm Medical Industries, Inc. | -325 Thousand USD | 65.99% |
QuantRx Biomedical Corporation | - USD | Infinity% |
Remedent, Inc. | -215.23 Thousand USD | 48.646% |
Reflect Scientific, Inc. | -405.78 Thousand USD | 72.761% |
SmileDirectClub, Inc. | -186.13 Million USD | 99.941% |
Sector 10, Inc. | - USD | Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 100.025% |
United Health Products, Inc. | -2.5 Million USD | 95.583% |
Vasamed, Inc. | -4.57 Million USD | 97.584% |
Wearable Health Solutions, Inc. | -2.26 Million USD | 95.111% |
Yubo International Biotech Limited | -1.17 Million USD | 90.615% |